Education
About Us
Working with TipRanks
Follow Us
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
OLMA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.07 - $16.62
Previous CloseN/A
Volume1.27M
Average Volume (3M)969.23K
Market Cap
$306.82M
Enterprise Value$470.65M
Total Cash (Recent Filing)$68.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.57
Next Earnings
May 13, 2025EPS Estimate
-0.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.19
Shares Outstanding68,333,060
10 Day Avg. Volume905,360
30 Day Avg. Volume969,231
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.40
P/FCF Ratio0.00
Enterprise Value/Market Cap1.53
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-1.25K
Enterprise Value/Ebitda-3.47
Forecast
1Y Price Target
$29.75Price Target Upside545.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
---
Olema Pharmaceuticals News
---
Bulls Say, Bears Say
Bulls Say
Efficacy Of TreatmentThe combo data of palazestrant and ribociclib show strong synergistic efficacy and consistent safety, suggesting best-in-class potential.
Strategic PartnershipsOlema announced a clinical trial collaboration and supply agreement with Novartis in frontline advanced ER+ breast cancer.
Bears Say
Market SentimentShort interest in the stock is relatively high at 15% of the float.
---
Ownership Overview
21.51% Insiders
8.82% Mutual Funds
0.31% Other Institutional Investors
60.19% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OLMA FAQ
What was Olema Pharmaceuticals’s price range in the past 12 months?
Olema Pharmaceuticals lowest stock price was $4.07 and its highest was $16.62 in the past 12 months.
What is Olema Pharmaceuticals’s market cap?
Olema Pharmaceuticals’s market cap is $306.82M.
When is Olema Pharmaceuticals’s upcoming earnings report date?
Olema Pharmaceuticals’s upcoming earnings report date is May 13, 2025 which is in 65 days.
How were Olema Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Olema Pharmaceuticals overvalued?
According to Wall Street analysts Olema Pharmaceuticals’s price is currently Undervalued.
Does Olema Pharmaceuticals pay dividends?
Olema Pharmaceuticals does not currently pay dividends.
What is Olema Pharmaceuticals’s EPS estimate?
Olema Pharmaceuticals’s EPS estimate is -0.64.
How many shares outstanding does Olema Pharmaceuticals have?
Olema Pharmaceuticals has 68,333,060 shares outstanding.
What happened to Olema Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Olema Pharmaceuticals?
Currently, no hedge funds are holding shares in OLMA
---
Olema Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.75 (545.34% Upside)
$29.75 (545.34% Upside)
Blogger Sentiment
Bullish
OLMA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 237.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $9.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days >0.1%
Last 30 Days ▼ 10.7%
Last 30 Days ▼ 10.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.23%
12-Months-Change
Fundamentals
Return on Equity
-51.76%
Trailing 12-Months
Asset Growth
-21.39%
Trailing 12-Months
Company Description
Olema Pharmaceuticals
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.
---
OLMA Stock 12 Month Forecast
Average Price Target
$29.75
▲(545.34% Upside)
Technical Analysis
Fate Therapeutics
―
Kura Oncology
―
Scholar Rock Holding
―
IGM Biosciences
―
ALX Oncology Holdings
―
Best Analysts Covering OLMA
1 Year
1 Year Success Rate
10/21 ratings generated profit
1 Year Average Return
+54.64%
reiterated a buy rating 4 days ago
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +54.64% per trade.
---